The molecular severity score was more predictive than every clinical feature in the MGH cohort (P < 0.0001 from AUC pairwise comparisons), which included age, BMI, pre-existing conditions (kidney, heart, and lung diseases, diabetes, hypertension and immunocompromised conditions), symptoms at presentation (respiratory, fever or gastrointestinal), or blood markers (lymphocytes, monocytes and neutrophils counts, CRP, creatinine, D-dimers, and LDH concentrations). This evidence concerns the gene CRP and hypertensive disorder.